OKYO Pharma (STU:OK10) Pretax Margin %: % (As of Sep. 2025)


STU:OK10 OKYO Pharma Ltd STU:OK10
23 GF Score
Price €2.16
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Pretax Margin %?

OKYO Pharma STU:OK10 23 Pretax Margin % is % as of Sep. 2025. GuruFocus rates STU:OK10 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 938 Biotechnology companies, OKYO Pharma ranks worse than 106609.7% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OKYO Pharma's Pre-Tax Income for the six months ended in Sep. 2025 was €-2.20 Mil. OKYO Pharma's Revenue for the six months ended in Sep. 2025 was €0.00 Mil. Therefore, OKYO Pharma's pretax margin for the quarter that ended in Sep. 2025 was %.

The historical rank and industry rank for OKYO Pharma's Pretax Margin % or its related term are showing as below:


STU:OK10's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.895
* Ranked among companies with meaningful Pretax Margin % only.

OKYO Pharma  (STU:OK10) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

OKYO Pharma Pretax Margin % Related Terms

OKYO Pharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Pretax Margin % Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:OK10 vs ENTX, HRTX, RANI: Pretax Margin % Comparison

For the Biotechnology subindustry, OKYO Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OKYO Pharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Pretax Margin % falls into.


STU:OK10
23GF Score
OKYO Pharma Ltd STU:OK10
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OKYO Pharma's Pretax Margin for the fiscal year that ended in Mar. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-7.372/0
= %

OKYO Pharma's Pretax Margin for the quarter that ended in Sep. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-2.204/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
OKYO Pharma (STU:OK10) has a Pretax Margin % of % as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #999999 out of 938 companies in the Biotechnology industry.
Is OKYO Pharma's Pretax Margin % too high?
OKYO Pharma's current Pretax Margin % is %. Based on the distribution chart, OKYO Pharma ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Pretax Margin % compare to ENTX and HRTX?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #999999 out of 938 companies for Pretax Margin %. This places OKYO Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (STU:OK10) has a current Pretax Margin % of %. The current Pretax Margin % is %. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For OKYO Pharma (STU:OK10), the current Pretax Margin % is % as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Other Exchanges OKYO:USA
Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for STU:OK10

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.16
Price